Speaker Profile
Ph.D., Head of Cellular and Tissue Genomics & Executive Dir, Genentech
Biography
Orit Rozenblatt-Rosen, PhD, is Head of the Cell and Tissue Genomics (CTG) Department at Genentech. CTG aims to develop and apply high resolution methods to characterize cells and tissues to accelerate scientific discovery and help identify targets and next-generation biomarkers for precision medicine treatments for patients. Orit is a pioneer in single-cell genomics technologies and their application to tissues in order to better understand health and disease. Previously, she was the Scientific Director of the Klarman Cell Observatory at the Broad Institute of MIT and Harvard, where she focused on deciphering cellular and tissue circuits. She also co-chairs the standards and technology working group for the Human Cell Atlas consortium.
Session Abstract – PMWC 2025 Silicon Valley
Track 4
Track Chair: Kathleen Barnes, Oxford Nanopore
Speakers:
Nobel Laureate Carol Greider, UCSC
Orit Rozenblatt-Rosen, Genentech
Emily Leproust, Twist
Session: Unraveling the molecular drivers of cancer requires a comprehensive understanding of its genetic, epigenetic, and proteomic complexities. This session explores how multi-omic technologies decode these intricate layers, providing insights into cancer's initiation, growth, and progression. By integrating diverse molecular data, researchers are uncovering actionable biomarkers, identifying therapeutic targets, and paving the way for breakthroughs in precision oncology. Join leading experts as they share cutting-edge advancements and strategies to overcome challenges in translating multi-omic research into clinical impact.
